{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:07:41Z","timestamp":1790834861573,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1U54HD071594"],"award-info":[{"award-number":["1U54HD071594"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1053\/j.semperi.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T21:08:01Z","timestamp":1557522481000},"page":"360-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity"],"prefix":"10.1053","volume":"43","author":[{"given":"Jacob V.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria B.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay D.","family":"Beharry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2019.05.009_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2016.04.014","article-title":"Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States","volume":"168","author":"Rothschild","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"9902","key":"10.1053\/j.semperi.2019.05.009_bib0003","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.semperi.2019.05.009_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10633-009-9181-x","article-title":"The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50\/10 OIR model","volume":"120","author":"Hartnett","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"10.1053\/j.semperi.2019.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/PDR.0b013e31817307ac","article-title":"Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy","volume":"64","author":"Coleman","year":"2008","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1053\/j.semperi.2019.05.009_bib0006","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2016.105","article-title":"Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy","volume":"80","author":"Aranda","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0007","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1167\/iovs.14-15321","article-title":"Exogenous superoxide dismutase mimetic without scavenging H2O2 causes photoreceptor damage in a rat model for oxygen-induced retinopathy","volume":"56","author":"Jivabhai Patel","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1053\/j.semperi.2019.05.009_bib0008","first-page":"7644","article-title":"Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats","volume":"54","author":"Beharry","year":"2013","journal-title":"IOVS"},{"issue":"4","key":"10.1053\/j.semperi.2019.05.009_bib0009","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.3390\/antiox6040103","article-title":"Co-enzyme Q10 and n-3 polyunsaturated fatty acid supplementation reverse intermittent hypoxia-induced growth restriction and improved antioxidant profiles in neonatal rats","volume":"6","author":"Beharry","year":"2017","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0010","first-page":"e488","article-title":"Impact of chronic neonatal intermittent hypoxia on severity of retinal damage in a rat model of oxygen-induced retinopathy","volume":"4","author":"Beharry","year":"2018","journal-title":"J Nat Sci"},{"issue":"5","key":"10.1053\/j.semperi.2019.05.009_bib0011","doi-asserted-by":"crossref","first-page":"E1337","DOI":"10.3390\/ijms19051337","article-title":"Oxygen-induced retinopathy from recurrent intermittent hypoxia is not dependent on resolution with room air or oxygen, in neonatal rats","volume":"19","author":"Beharry","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1053\/j.semperi.2019.05.009_bib0012","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/aps.2013.94","article-title":"Hypoxia\/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation","volume":"34","author":"Gao","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1053\/j.semperi.2019.05.009_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-94-007-4584-1_47","article-title":"Physiologic basis for intermittent hypoxic episodes in preterm infants","volume":"758","author":"Martin","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.semperi.2019.05.009_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.jp.7211040","article-title":"Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants","volume":"24","author":"York","year":"2004","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2019.05.009_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0016","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/pr.2012.132","article-title":"The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants","volume":"72","author":"Di Fiore","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9394(99)80239-6","article-title":"A global initiative for the elimination of avoidable blindness","volume":"125","author":"Thylefors","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1053\/j.semperi.2019.05.009_bib0018","first-page":"227","article-title":"Childhood blindness in the context of Vision 2020\u2014the right to sight","volume":"79","author":"Gilbert","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1053\/j.semperi.2019.05.009_bib0019","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1350-9462(01)00012-X","article-title":"Development of the primate retinal vasculature","volume":"20","author":"Provis","year":"2001","journal-title":"Prog Ret Eye Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0021","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.73.6.1100","article-title":"A redox-based O2 sensor in rat pulmonary vasculature","volume":"73","author":"Archer","year":"1993","journal-title":"Circ Res"},{"issue":"15","key":"10.1053\/j.semperi.2019.05.009_bib0022","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.4161\/cc.10.15.16870","article-title":"Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs \u201cfertilizer\u201d","volume":"10","author":"Lisanti","year":"2011","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1053\/j.semperi.2019.05.009_bib0023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.siny.2010.04.001","article-title":"Maturation of the antioxidant system and the effects on preterm birth","volume":"15","author":"Davis","year":"2010","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2019.05.009_bib0024","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"The toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82-83","author":"Winterbourn","year":"1995","journal-title":"Toxicol Lett"},{"key":"10.1053\/j.semperi.2019.05.009_bib0025","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1136\/fn.84.3.F188","article-title":"Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants","volume":"84","author":"Hirano","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1053\/j.semperi.2019.05.009_bib0026","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-5793(92)80911-Y","article-title":"Biologically relevant metal ion-dependent hydroxyl radical generation. An update","volume":"307","author":"Halliwell","year":"1992","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1053\/j.semperi.2019.05.009_bib0027","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000330174","article-title":"Understanding retinopathy of prematurity: update on pathogenesis","volume":"100","author":"Rivera","year":"2011","journal-title":"Neonatology"},{"key":"10.1053\/j.semperi.2019.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/eye.2008.21","article-title":"Adult vitreous structure and postnatal changes","volume":"22","author":"LeGoff","year":"2008","journal-title":"Eye"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamaophthalmol.2018.5984","article-title":"Retinopathy of prematurity workgroup of the international neonatal consortium. development of a retinopathy of prematurity activity scale and clinical outcome measures for use in clinical trials","volume":"137","author":"Smith","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000322848","article-title":"A paradigm shift in the prevention of retinopathy of prematurity","volume":"100","author":"Raghuveer","year":"2011","journal-title":"Neonatology"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0031","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000329922","article-title":"Intermittent hypoxic episodes in preterm infants: do they matter?","volume":"100","author":"Martin","year":"2011","journal-title":"Neonatology"},{"issue":"9","key":"10.1053\/j.semperi.2019.05.009_bib0032","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00417-013-2321-8","article-title":"Early retinopathy of prematurity findings identified with fluorescein angiography","volume":"251","author":"Zepeda-Romero","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0033","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0034","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J AAPOS"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"issue":"11","key":"10.1053\/j.semperi.2019.05.009_bib0036","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1592\/phco.28.11.1335","article-title":"Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants","volume":"28","author":"Schneider","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1053\/j.semperi.2019.05.009_bib0037","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics"},{"issue":"12","key":"10.1053\/j.semperi.2019.05.009_bib0038","first-page":"1341","article-title":"Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'","volume":"142","author":"Sullivan","year":"1988","journal-title":"Am J Dis Child"},{"issue":"6","key":"10.1053\/j.semperi.2019.05.009_bib0039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s004310050641","article-title":"Blood transfusion. Iron load and retinopathy of prematurity","volume":"156","author":"Hesse","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0040","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine for apnea of prematurity trial group. Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"NEJM"},{"key":"10.1053\/j.semperi.2019.05.009_bib0041","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Caffeine for apnea of prematurity trial group. Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"NEJM"},{"key":"10.1053\/j.semperi.2019.05.009_bib0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/mol.106.032920","article-title":"Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells","volume":"72","author":"Merighi","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.semperi.2019.05.009_bib0043","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcp.22180","article-title":"Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+\/ROS-mediated suppression of ERK\/c-fos pathway and activation of p38 MAPK\/c-jun pathway","volume":"224","author":"Liu","year":"2010","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2019.05.009_bib0044","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/pr501238m","article-title":"Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach","volume":"14","author":"Tu","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0045","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/S0028-3908(00)00045-9","article-title":"Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells","volume":"39","author":"Fiebich","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1053\/j.semperi.2019.05.009_bib0046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2007.02.016","article-title":"Caffeine as an adjuvant to ibuprofen in treating childhood headaches","volume":"37","author":"Dooley","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1053\/j.semperi.2019.05.009_bib0047","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0048","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000087587","article-title":"IGF-1 and retinopathy of prematurity in the preterm infant","volume":"88","author":"Smith","year":"2005","journal-title":"Biol Neonate"},{"key":"10.1053\/j.semperi.2019.05.009_bib0049","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","author":"Ley","year":"2018","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jp.2014.195","article-title":"Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity","volume":"35","author":"Harris","year":"2015","journal-title":"J Perinatol"},{"issue":"7","key":"10.1053\/j.semperi.2019.05.009_bib0051","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat Med"},{"key":"10.1053\/j.semperi.2019.05.009_bib0052","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","article-title":"Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study","volume":"38","author":"Pawlik","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0053","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.2010-2427","article-title":"Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants","volume":"127","author":"Pawlik","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1053\/j.semperi.2019.05.009_bib0054","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","article-title":"The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial","volume":"90","author":"Beken","year":"2014","journal-title":"Early Hum Dev"},{"key":"10.1053\/j.semperi.2019.05.009_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","article-title":"Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial","volume":"20","author":"Najm","year":"2017","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0056","article-title":"Early introduction of lipids to parenterally-fed preterm infants","author":"Simmer","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2019.05.009_bib0057","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/ajcn\/87.4.912","article-title":"Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials","volume":"87","author":"Smithers","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1053\/j.semperi.2019.05.009_bib0058","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1570159X13666151102103305","article-title":"Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders","volume":"13","author":"Yui","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0059","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy","volume":"108","author":"Sennlaub","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.semperi.2019.05.009_bib0060","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1167\/iovs.09-3652","article-title":"The role of PGE2 receptor EP4 in pathologic ocular angiogenesis","volume":"50","author":"Yanni","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1053\/j.semperi.2019.05.009_bib0061","first-page":"4574","article-title":"Thromboxane A2 is a mediator of cyclooxygenase-2 dependent endothelial migration and angiogenesis","volume":"59","author":"Daniel","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0062","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0008-6363(00)00084-5","article-title":"Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy","volume":"47","author":"Hardy","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0063","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jpeds.2008.05.009","article-title":"Indomethacin and retinopathy of prematurity: the hidden paradox","volume":"153","author":"Hammerman","year":"2008","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0064","first-page":"415","article-title":"Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study","volume":"7","author":"Avila-Vazquez","year":"2004","journal-title":"BMC Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1203\/00006450-199908000-00010","article-title":"Indomethacin improves oxygen-induced retinopathy of prematurity in the mouse","volume":"46","author":"Nandgaonkar","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0066","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1076\/ceyr.27.5.309.17222","article-title":"Ibuprofen improves oxygen-induced retinopathy in a mouse model","volume":"27","author":"Sharma","year":"2003","journal-title":"Curr Eye Res"},{"key":"10.1053\/j.semperi.2019.05.009_bib0067","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1167\/iovs.02-0346","article-title":"Topical nepafenac inhibits ocular neovascularization","volume":"44","author":"Takahashi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1053\/j.semperi.2019.05.009_bib0068","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.79.4.489","article-title":"Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial","volume":"79","author":"Phelps","year":"1987","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2019.05.009_bib0069","unstructured":"Rosenbaum AL, Phelps DL, Isenberg SJ, Leake RD, Dorey F. Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment."},{"key":"10.1053\/j.semperi.2019.05.009_bib0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.nutr.23.011702.073307","article-title":"Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye","volume":"23","author":"Krinsky","year":"2003","journal-title":"Ann Rev Nutr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0071","doi-asserted-by":"crossref","first-page":"567S","DOI":"10.1080\/07315724.2004.10719427","article-title":"Lutein and zeaxanthin and their potential roles in disease prevention","volume":"23","author":"Ribaya-Mercado","year":"2004","journal-title":"J Am Coll Nutr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0072","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/14767058.2011.629252","article-title":"Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study","volume":"25","author":"Dani","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2019.05.009_bib0073","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14767058.2011.607618","article-title":"A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity","volume":"24","author":"Romagnoli","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1053\/j.semperi.2019.05.009_bib0074","first-page":"25","article-title":"Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial","volume":"30","author":"Manzoni","year":"2013","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1053\/j.semperi.2019.05.009_bib0076","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1053\/j.semperi.2019.05.009_bib0077","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2019.05.009_bib0078","article-title":"Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants","volume":"3","author":"Kaempfen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.semperi.2019.05.009_bib0079","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.semperi.2019.05.009_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.semperi.2015.12.006","article-title":"Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity","volume":"40","author":"Beharry","year":"2016","journal-title":"Semin Perinatol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000519300692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000519300692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:54:19Z","timestamp":1758938059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000519300692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0146000519300692"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2019.05.009","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}